Literature DB >> 22280445

Regulation of the intersubunit ammonia tunnel in Mycobacterium tuberculosis glutamine-dependent NAD+ synthetase.

Watchalee Chuenchor1, Tzanko I Doukov, Melissa Resto, Andrew Chang, Barbara Gerratana.   

Abstract

Glutamine-dependent NAD+ synthetase is an essential enzyme and a validated drug target in Mycobacterium tuberculosis (mtuNadE). It catalyses the ATP-dependent formation of NAD+ from NaAD+ (nicotinic acid-adenine dinucleotide) at the synthetase active site and glutamine hydrolysis at the glutaminase active site. An ammonia tunnel 40 Å (1 Å=0.1 nm) long allows transfer of ammonia from one active site to the other. The enzyme displays stringent kinetic synergism; however, its regulatory mechanism is unclear. In the present paper, we report the structures of the inactive glutaminase C176A variant in an apo form and in three synthetase-ligand complexes with substrates (NaAD+/ATP), substrate analogue {NaAD+/AMP-CPP (adenosine 5'-[α,β-methylene]triphosphate)} and intermediate analogues (NaAD+/AMP/PPi), as well as the structure of wild-type mtuNadE in a product complex (NAD+/AMP/PPi/glutamate). This series of structures provides snapshots of the ammonia tunnel during the catalytic cycle supported also by kinetics and mutagenesis studies. Three major constriction sites are observed in the tunnel: (i) at the entrance near the glutaminase active site; (ii) in the middle of the tunnel; and (iii) at the end near the synthetase active site. Variation in the number and radius of the tunnel constrictions is apparent in the crystal structures and is related to ligand binding at the synthetase domain. These results provide new insight into the regulation of ammonia transport in the intermolecular tunnel of mtuNadE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22280445     DOI: 10.1042/BJ20112210

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  6 in total

1.  Evidence for hysteretic substrate channeling in the proline dehydrogenase and Δ1-pyrroline-5-carboxylate dehydrogenase coupled reaction of proline utilization A (PutA).

Authors:  Michael A Moxley; Nikhilesh Sanyal; Navasona Krishnan; John J Tanner; Donald F Becker
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

2.  Design, synthesis, and evaluation of substituted nicotinamide adenine dinucleotide (NAD+) synthetase inhibitors as potential antitubercular agents.

Authors:  Xu Wang; Yong-Mo Ahn; Adam G Lentscher; Julia S Lister; Robert C Brothers; Malea M Kneen; Barbara Gerratana; Helena I Boshoff; Cynthia S Dowd
Journal:  Bioorg Med Chem Lett       Date:  2017-08-08       Impact factor: 2.823

3.  Biochemical and structural characterization of oxygen-sensitive 2-thiouridine synthesis catalyzed by an iron-sulfur protein TtuA.

Authors:  Minghao Chen; Shin-Ichi Asai; Shun Narai; Shusuke Nambu; Naoki Omura; Yuriko Sakaguchi; Tsutomu Suzuki; Masao Ikeda-Saito; Kimitsuna Watanabe; Min Yao; Naoki Shigi; Yoshikazu Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

4.  Kinetics and structural features of dimeric glutamine-dependent bacterial NAD+ synthetases suggest evolutionary adaptation to available metabolites.

Authors:  Adrian Richard Schenberger Santos; Edileusa Cristina Marques Gerhardt; Vivian Rotuno Moure; Fábio Oliveira Pedrosa; Emanuel Maltempi Souza; Riccardo Diamanti; Martin Högbom; Luciano Fernandes Huergo
Journal:  J Biol Chem       Date:  2018-03-26       Impact factor: 5.157

5.  Glutamine versus ammonia utilization in the NAD synthetase family.

Authors:  Jessica De Ingeniis; Marat D Kazanov; Konstantin Shatalin; Mikhail S Gelfand; Andrei L Osterman; Leonardo Sorci
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

6.  Different ways to transport ammonia in human and Mycobacterium tuberculosis NAD+ synthetases.

Authors:  Watchalee Chuenchor; Tzanko I Doukov; Kai-Ti Chang; Melissa Resto; Chang-Soo Yun; Barbara Gerratana
Journal:  Nat Commun       Date:  2020-01-07       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.